Tsuchiya Satoshi, Saiga Atsushi, Yokota Hajime, Kubota Yoshihiro, Wada Takeshi, Akutsu Akira, Koizumi Jun, Aramaki Takeshi, Uno Takashi
Division of Interventional Radiology, Shizuoka Cancer Center, Japan.
Department of Radiology, Chiba University Hospital, Japan.
Interv Radiol (Higashimatsuyama). 2023 Mar 1;8(1):1-6. doi: 10.22575/interventionalradiology.2021-0015.
Postembolization syndrome (PES) after renal arterial embolization (RAE) can reduce the patient's tolerance of the procedure and extend the length of hospital stay. We aimed to assess the efficacy of steroid administration in preventing PES in patients undergoing RAE for angiomyolipoma (AML).
Between May 2004 and March 2020, 29 RAE procedures in 26 patients with AML were performed. Patient information, including age, sex, tumor size, tuberous sclerosis complex-associated/sporadic AML, hemorrhagic/nonhemorrhagic AML, embolic material, steroid use, medication type, some blood laboratory parameters, hospital stay, and PES occurrence were retrospectively obtained. The prophylactic steroid protocol used in the study was as follows: 250 mg of intravenous methylprednisolone (Solu-Medrol) 2 h before the RAE procedure, followed by 2 days of intravenous prednisolone (Predonine; 2 mg/kg/day), which was tapered by halving the dose every 2 days within the course of 2 weeks. After the discharge, intravenous prednisolone was changed to oral prednisolone (Predonine). PES was defined as the presence of fever, pain, nausea, or vomiting. Data were compared between the steroid and non-steroid groups and between PES and non-PES groups.
The PES incidence rate was 76%, and a comparison between the steroid and non-steroid groups revealed that steroid use significantly decreased the incidence of PES (P < 0.001), including fever (P < 0.001), pain (P = 0.005), and nausea (P = 0.028). The use of anti-inflammatory drugs during the hospital stay was significantly lower in the steroid group (P = 0.019). Moreover, in the steroid group, C-reactive protein level was significantly lower (P = 0.006), whereas white blood cell count was significantly higher (P = 0.004). Conversely, the median length of hospital stay was not significantly shorter in the steroid group (P = 0.292).
The prophylactic use of steroids before and after embolization of renal AML may be effective in preventing PES in this small retrospective study.
肾动脉栓塞术(RAE)后的栓塞后综合征(PES)会降低患者对该手术的耐受性并延长住院时间。我们旨在评估类固醇给药对接受RAE治疗肾血管平滑肌脂肪瘤(AML)患者预防PES的疗效。
2004年5月至2020年3月期间,对26例AML患者进行了29次RAE手术。回顾性获取患者信息,包括年龄、性别、肿瘤大小、结节性硬化症相关/散发性AML、出血性/非出血性AML、栓塞材料、类固醇使用情况、药物类型、一些血液实验室参数、住院时间和PES发生情况。本研究中使用的预防性类固醇方案如下:在RAE手术前2小时静脉注射250毫克甲泼尼龙(甲强龙),随后静脉注射泼尼松龙(强的松龙;2毫克/千克/天)2天,在2周内每2天将剂量减半逐渐减量。出院后,静脉注射泼尼松龙改为口服泼尼松龙(强的松龙)。PES定义为出现发热、疼痛、恶心或呕吐。对类固醇组和非类固醇组以及PES组和非PES组的数据进行比较。
PES发生率为76%,类固醇组和非类固醇组之间的比较显示,使用类固醇显著降低了PES的发生率(P<0.001),包括发热(P<0.001)、疼痛(P=0.005)和恶心(P=0.028)。类固醇组住院期间使用抗炎药物的情况显著较少(P=0.019)。此外,在类固醇组中,C反应蛋白水平显著较低(P=0.006),而白细胞计数显著较高(P=0.004)。相反,类固醇组的中位住院时间并没有显著缩短(P=0.292)。
在这项小型回顾性研究中,肾AML栓塞前后预防性使用类固醇可能对预防PES有效。